Ma F H, Hu H T, Tian Y T
Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing100021, China.
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):180-183. doi: 10.3760/cma.j.cn112152-20200223-00117.
The outbreak of COVID-19 occurred in Wuhan, Hubei province of China, at the end of 2019, and spread rapidly across the country. After the outbreak of this disease, the overwhelming majority of cities have launched the "first level response" and the regular diagnosis and treatment of cancer patients are greatly affected. The digestive systemic cancer is the most common malignancy. Most patients are diagnosed in the advanced stage with poor prognosis. The epidemic of COVID-19 poses new challenges to diagnosis and treatment of the patients with digestive system malignancies. Based on the fully understanding of the characteristics of digestive system tumors, we should change the treatment strategy and adopt more reasonable treatment strategy timely during the epidemic period to minimize the adverse effects of the epidemic of COVID-19 on the treatment.
2019年底，新型冠状病毒肺炎（COVID-19）疫情在中国湖北省武汉市爆发，并迅速蔓延至全国。该疾病爆发后，绝大多数城市启动了“一级响应”，癌症患者的常规诊断和治疗受到极大影响。消化系统癌症是最常见的恶性肿瘤。大多数患者在晚期被诊断出来，预后较差。COVID-19疫情给消化系统恶性肿瘤患者的诊断和治疗带来了新的挑战。基于对消化系统肿瘤特征的充分了解，我们应在疫情期间及时改变治疗策略，采取更合理的治疗方案，以尽量减少COVID-19疫情对治疗的不利影响。
